基于随机化的协方差分析:分类时间事件数据的限制平均生存时间置信区间
本文提出一种基于随机化的协方差分析方法,用于在随机对照试验中比较治疗组间限制平均生存时间(RMST),通过约束协变量均值差为零提高精度,并给出置信区间。方法适用于两治疗组单/多时间区间及多治疗组单区间比较,并用一项评估三种剂量药物治疗ALS的随机双盲安慰剂对照试验数据演示。
要点
- 基于随机化的协方差分析可提高RMST治疗差异置信区间的精度。
- 方法适用于分类时间事件数据,无需模型假设。
- 支持两治疗组多时间区间及多治疗组单区间比较。
核心结论
- 基于随机化的协方差分析为协变量调整的RMST比较提供了不依赖模型假设的方法,置信区间比未调整的RMST差异更精确。
研究设计与样本
- 方法学论文,提出基于随机化的协方差分析(RB-ANCOVA)用于分类时间事件数据的RMST协变量调整比较。
- 使用一项评估三种剂量试验药物治疗ALS的随机双盲安慰剂对照临床试验数据进行方法演示。
主要发现
- 通过约束治疗组间协变量均值差异为零,估计RMST的治疗差异。
- 相应置信区间比基于未调整RMST差异的置信区间提供更大精度。
临床怎么用
- 在随机对照试验的RMST分析中,可采用基于随机化的协方差分析进行协变量调整,以提高治疗比较的精度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This paper introduces a randomization-based method for covariate-adjusted comparisons of restricted mean survival time (RMST) between treatment arms in randomized controlled trials. Existing approaches for covariate-adjusted RMST analysis have model-based assumptions that may not be compatible with the complexity of survival data. We estimate the treatment difference in RMST using randomization-based analysis of covariance (RB-ANCOVA) for categorized time-to-event data by constraining the covariate mean differences between treatment groups to zero. Accordingly, we provide corresponding confidence intervals that offer greater precision than those based on unadjusted RMST differences. The methodology is detailed for comparing two treatment groups for a single or multiple time intervals, as well as for multiple treatment groups over a single interval. We demonstrate the application of these methods using data from a randomized, double-blind, placebo-controlled clinical trial evaluating three doses of a test treatment for ALS.
引用
- Krajewski T, Koch G. Randomization-Based Covariance Analysis for Confidence Intervals of Treatment Comparisons Based on Restricted Mean Survival Time With Categorized Time-to-Event Data. Stat Med. 2026. PMID: 41925076. doi:10.1002/sim.70422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。